330 related articles for article (PubMed ID: 21385367)
21. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia.
Boussekey N; Leroy O; Alfandari S; Devos P; Georges H; Guery B
Intensive Care Med; 2006 Mar; 32(3):469-72. PubMed ID: 16477418
[TBL] [Abstract][Full Text] [Related]
22. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.
España PP; Capelastegui A; Bilbao A; Diez R; Izquierdo F; Lopez de Goicoetxea MJ; Gamazo J; Medel F; Salgado J; Gorostiaga I; Quintana JM;
Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3397-405. PubMed ID: 23010902
[TBL] [Abstract][Full Text] [Related]
23. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
[TBL] [Abstract][Full Text] [Related]
24. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock.
Hatherill M; Tibby SM; Turner C; Ratnavel N; Murdoch IA
Crit Care Med; 2000 Jul; 28(7):2591-4. PubMed ID: 10921600
[TBL] [Abstract][Full Text] [Related]
25. Procalcitonin kinetics in Legionella pneumophila pneumonia.
de Jager CP; de Wit NC; Weers-Pothoff G; van der Poll T; Wever PC
Clin Microbiol Infect; 2009 Nov; 15(11):1020-5. PubMed ID: 19438643
[TBL] [Abstract][Full Text] [Related]
26. [Ventilator bundle treatment of acute respiratory distress syndrome and its correlation with biomarkers of inflammation].
Yang J; Dong C; Li J; Zhang H; Zhang H; Song R; Yang Z; Feng F; Qi Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Aug; 26(8):544-8. PubMed ID: 25124901
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y
Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
[TBL] [Abstract][Full Text] [Related]
28. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
Lindstrom ST; Wong EK
Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
[TBL] [Abstract][Full Text] [Related]
29. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.
Huang DT; Angus DC; Kellum JA; Pugh NA; Weissfeld LA; Struck J; Delude RL; Rosengart MR; Yealy DM
Chest; 2009 Sep; 136(3):823-831. PubMed ID: 19363212
[TBL] [Abstract][Full Text] [Related]
30. Mortality prediction in community-acquired pneumonia requiring mechanical ventilation; values of pneumonia and intensive care unit severity scores.
Aydoğdu M; Ozyilmaz E; Aksoy H; Gürsel G; Ekim N
Tuberk Toraks; 2010; 58(1):25-34. PubMed ID: 20517726
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of procalcitonin in Legionella pneumonia.
Haeuptle J; Zaborsky R; Fiumefreddo R; Trampuz A; Steffen I; Frei R; Christ-Crain M; Müller B; Schuetz P
Eur J Clin Microbiol Infect Dis; 2009 Jan; 28(1):55-60. PubMed ID: 18677519
[TBL] [Abstract][Full Text] [Related]
32. Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia.
Courtais C; Kuster N; Dupuy AM; Folschveiller M; Jreige R; Bargnoux AS; Guiot J; Lefebvre S; Cristol JP; Sebbane M
Am J Emerg Med; 2013 Jan; 31(1):215-21. PubMed ID: 23000327
[TBL] [Abstract][Full Text] [Related]
33. [Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].
Hao C; Hu Q; Zhu L; Xu H; Zhang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):281-285. PubMed ID: 33834968
[TBL] [Abstract][Full Text] [Related]
34. Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia.
Kim MW; Lim JY; Oh SH
Scand J Clin Lab Invest; 2017 Nov; 77(7):486-492. PubMed ID: 28678546
[TBL] [Abstract][Full Text] [Related]
35. Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients.
Karhu J; Ala-Kokko TI; Ylipalosaari P; Ohtonen P; Laurila JJ; Syrjälä H
Acta Anaesthesiol Scand; 2011 Nov; 55(10):1254-60. PubMed ID: 22092131
[TBL] [Abstract][Full Text] [Related]
36. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of procalcitonin in community-acquired pneumonia.
Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
[TBL] [Abstract][Full Text] [Related]
38. Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report.
Charles PE; Kus E; Aho S; Prin S; Doise JM; Olsson NO; Blettery B; Quenot JP
BMC Infect Dis; 2009 Apr; 9():49. PubMed ID: 19386110
[TBL] [Abstract][Full Text] [Related]
39. [The correlation between procalcitonin, C-reactive protein and severity scores in patients with sepsis and their value in assessment of prognosis].
Wang S; Chen D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):97-101. PubMed ID: 25665606
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
